Introduction {#s01}
============

Cytokines and growth factors precisely control the dynamics of lymphocyte behavior during an immune response. Upon initial antigen exposure, prostimulatory cytokines, such as IL-2, mediate lymphocyte activation by promoting nutrient uptake and metabolism to support cell growth and proliferation ([@bib12]; [@bib28]; [@bib35]). When an infection is cleared, levels of IL-2 and other growth factors decrease, leading to decreased nutrient uptake, cell cycle arrest, atrophy, and apoptosis of most activated lymphocytes. A small surviving fraction of these cells differentiates into memory cells, also through a cytokine-mediated process ([@bib46]; [@bib42]).

The absence of proinflammatory cytokine signaling limits nutrient uptake in memory cells ([@bib10]; [@bib36]), though several mechanisms have been identified for maintaining viability under these conditions. First, memory cells undergo a significant metabolic shift; whereas activated cells consume large amounts of glucose to support proliferation, memory cells limit metabolic expenditures almost exclusively to maintenance functions. Correspondingly, memory lymphocytes rely on oxidative phosphorylation to extract the maximum amount of energy from available nutrients ([@bib17]; [@bib31]). Autophagy, or self-digestion of intracellular components, also plays an essential role in memory lymphocyte survival in the absence of IL-2 by providing an alternative source of metabolic precursors ([@bib25]). Finally, the anti-apoptotic protein Bcl-2 is up-regulated in memory lymphocytes relative to effector lymphocytes, helping to promote memory cell differentiation and survival ([@bib29]; [@bib18]; [@bib45]). Bcl-2 also aids in the bioenergetic adaptation to decreased nutrient uptake and remains elevated in memory cells for an extended period after an infection has been cleared ([@bib29]; [@bib18]).

Memory differentiation of effector lymphocytes also involves a decrease in cell size, a response previously attributed to autophagy ([@bib34]; [@bib4]; [@bib49]). Biophysical properties, such as cell mass, volume, and density, represent aggregate changes in cellular composition, and measuring changes in these properties can reveal adaptations that may be obscured when investigating individual molecular events or pathways in isolation ([@bib16]; [@bib19]; [@bib30]; [@bib7]; [@bib15]). Here, we analyze cell size, described in terms of volume, as well as cell density, or mass per volume, of single lymphocytes to better understand the effects of growth factor withdrawal. Although cell volume and mass are measures of combined cell water and biochemical content, density represents the contribution of each to overall cellular composition. Cell density is very tightly regulated and can therefore reveal changes to cell state beyond those suggested by changes in cell volume alone ([@bib16]; [@bib19]; [@bib30]; [@bib5]; [@bib8]).

To study the response of lymphocytes to growth factor withdrawal, we examined FL5.12 cells, mouse pro--B lymphocytes that depend on IL-3 for nutrient uptake and growth. In the absence of IL-3, these cells lose the ability to take up nutrients and consequently undergo atrophy and apoptosis. However, when the prosurvival Bcl-2--related protein Bcl-x~L~ is expressed, or proapoptotic proteins are lost, apoptosis is inhibited and cells rely on autophagy for long-term survival ([@bib43]; [@bib34]; [@bib24]). Here, we show that changes to cell volume and density occur as an acute response to growth factor depletion and that this response aids adaptation to decreased nutrient uptake before autophagy induction in both FL5.12 cells and primary monoclonal CD8^+^ cells.

Results {#s02}
=======

IL-3 depletion results in both volume and density changes in FL5.12 Bcl-x~L~ cells {#s03}
----------------------------------------------------------------------------------

To understand the biophysical effects of growth factor withdrawal, we studied FL5.12 cells, a pro--B lymphocytic cell line dependent on IL-3 for survival. As previously reported, wild-type FL5.12 cells (FL5.12 WT), but not FL5.12 cells expressing Bcl-x~L~ (FL5.12 Bcl-x~L~), undergo apoptosis within 24 h of IL-3 depletion ([Fig. S1 a](http://www.jcb.org/cgi/content/full/jcb.201506118/DC1){#supp1}; [@bib38]; [@bib43]). Thus, to investigate the biophysical effects of growth factor deprivation independent of apoptosis, we used FL5.12 Bcl-x~L~ cells. We used a suspended microchannel resonator (SMR) to measure changes to the volume and density of FL5.12 Bcl-x~L~ cells after depletion of IL-3 for up to 120 h. The SMR is a microfluidic cantilever-based mass sensor used to determine the mass of a single cell in a fluid---the buoyant mass---based on changes in resonance frequency ([@bib6]). By measuring the buoyant mass of the same cell in two fluids of two different densities, we can calculate the total volume and density of that cell ([Fig. 1](#fig1){ref-type="fig"} and Materials and methods; [@bib19]). After IL-3 depletion, we found that cell volume decreases continuously for the entire measurement period, though most dramatically over the first 24 h ([Fig. 2 a](#fig2){ref-type="fig"}). Similar findings are observed when cell volume is assessed using a Coulter counter (Fig. S1 b) and are in agreement with previous studies ([@bib34]; [@bib13]). The density of growth factor--depleted cells increases continuously over the same time period ([Fig. 2 b](#fig2){ref-type="fig"}). These results are in contrast with measurements performed in apoptotic FL5.12 WT cells, which show only a slight decrease in volume and a decrease in density upon IL-3 depletion (Fig. S1, c and d). Cell density is the ratio of cell mass to volume, and also represents a weighted mean of the densities of all cellular components. Thus, an increase in cell density is likely characterized by an increase in the amount of high-density material, such as nucleic acids and proteins, relative to low-density material, such as water; nonetheless, the decrease in cell volume indicates the potential for loss of both aqueous and nonaqueous material.

![**Graphical description of how cell volume and density can be obtained from buoyant mass measurements.** A cell is first flowed into the SMR, and its buoyant mass is measured in low-density fluid (red). The cell is then trapped in the high-density fluid (blue), and then the direction of fluid flow is switched. The cell is then flowed through the SMR in the opposite direction where buoyant mass is measured in the high-density fluid. Volume and density are then calculated as shown in the plot on the left.](JCB_201506118_Fig1){#fig1}

![**Biophysical changes resulting from IL-3 depletion in FL5.12 Bcl-x~L~ cells.**SMR measurements demonstrate a decrease in volume (a) and increase in density (b) over a 120-h interval. \*, P \< 2 × 10^−26^. Representative images (c) and aggregate data (d) from high-throughput cell phenotyping (htCP) performed on control cells and 120 h after IL-3 depletion. Bars, 10 µm. Fractionation of FL5.12 Bcl-x~L~ cells labeled with ^14^C to show the relative loss of different biomass components after IL-3 withdrawal (e).](JCB_201506118_Fig2){#fig2}

We wished to confirm that the biophysical changes that we observed were not limited to Bcl-x~L~--expressing FL5.12 cells. We therefore depleted IL-3 from Bcl-2--expressing FL5.12 cells and found that volume decreased and density increased in a similar manner to Bcl-x~L~--expressing cells (Fig. S1, e and f). To determine the degree of loss of nonaqueous material, we used an SMR to measure the dry mass ([@bib15]; [@bib27]) of FL5.12 Bcl-x~L~ cells depleted of IL-3 for up to 120 h. We observed a decrease in cell dry mass that occurs simultaneously with the changes to volume and density, suggesting that cells also lose macromolecular material (Fig. S1 g). These findings indicate that not all cellular material is lost in equal amounts and suggests that the initial response to growth factor withdrawal is a large decrease in cell size with selective conservation of high-density material.

To further analyze the intracellular content of the IL-3--depleted FL5.12 cells, we used high-throughput cell phenotying (htCP), a single-cell resolution microscopy-based assay, to quantitatively determine morphometric parameters of immuno-stained cells and fluorescence intensity of antibody-specific intracellular components ([@bib9]). F-actin, mitochondria, and nuclei were stained and analyzed using htCP before and after IL-3 depletion ([Fig. 2 c](#fig2){ref-type="fig"}). As shown in [Fig. 2 d](#fig2){ref-type="fig"}, though both nuclear area and cellular area decrease 5 days after IL-3 depletion, the nuclear to cytoplasmic ratio increases, indicating a greater relative loss of cytoplasmic volume. Moreover, mitochondrial content only decreases slightly, further suggesting that material contained in the nucleus and mitochondria is preferentially retained. To orthogonally measure changes to cellular composition after growth factor withdrawal, we performed a cellular fractionation of radioactively labeled components. In this measurement, we cultured FL5.12 Bcl-x~L~ or WT cells in ^14^C glucose until labeling reached steady state. Cells were then either maintained in, or depleted of, IL-3 for 24 h (in media with ^14^C glucose) and cells were fractionated to determine the relative amounts of ^14^C present in each fraction: organic (lipids and nonpolar molecules), polar (metabolites and other small polar molecules), protein, RNA, and DNA. Because all cells should have similar amounts of DNA, we normalized the amount of ^14^C in each fraction to the amount of ^14^C present in the DNA fraction. As shown in [Fig. 2 e](#fig2){ref-type="fig"}, IL-3 depletion of FL5.12 Bcl-x~L~ cells leads to a large decrease in the amount of RNA and polar material and smaller decreases in the protein and organic content. These trends are enhanced in FL5.12 WT cells, which are dying at the time of the measurement (Fig. S1 a). These data indicate that some components of cellular biomass are conserved in FL5.12 Bcl-x~L~ cells deprived of IL-3, whereas others are selectively lost.

To determine whether the increase in cell density was reversible, we added IL-3 back to a population of cells depleted of IL-3 for 120 h and measured changes in cell density, volume, and proliferation rate over a period of 96 h, which was the amount of time required for cells to return to previous rates of proliferation ([Table S1](http://www.jcb.org/cgi/content/full/jcb.201506118/DC1){#supp2}). We found that cell volume begins to increase within 24 h after IL-3 repletion and returns to the value observed in proliferating cells within 72 h (Fig. S1 i). Interestingly, we found that density decreases to the value observed in proliferating cells within 24 h of IL-3 repletion, then decreases further, and again increases back to the value observed in proliferating cells within 96 h (Fig. S1 j).

Autophagy and IL-3 depletion lead to different biophysical changes {#s04}
------------------------------------------------------------------

Induction of autophagy is a response that allows FL5.12 Bcl-x~L~ cells to maintain ATP synthesis, and therefore viability, during prolonged depletion of IL-3 ([@bib23]; [@bib24]; [@bib42]; [@bib2]). To determine whether activation of autophagy might drive the biophysical changes we observed after IL-3 depletion, we used Torin 1, an ATP-competitive inhibitor of mammalian target of rapamycin (mTOR; [@bib13]; [@bib41]), to induce autophagy in FL5.12 Bcl-x~L~ cells cultured in the presence of IL-3. mTOR signaling suppresses autophagy, and has been shown to be a downstream effector of IL-3 ([@bib39]; [@bib11]; [@bib48]). As shown in [Fig. 3 (a and b)](#fig3){ref-type="fig"}, cells treated with Torin 1 undergo a slight decrease in both volume and density ([@bib41]). This phenotype contrasts with the larger decrease in volume and increase in density observed after IL-3 depletion ([Fig. 2, a and b](#fig2){ref-type="fig"}). To determine whether Torin 1 treatment resulted in autophagy in FL5.12 Bcl-x~L~ cells, we measured the conversion of LC3-I to LC3-II, a marker of autophagy ([@bib21]). Torin 1 led to near maximal production of LC3-II within 6 h, confirming the induction of autophagy ([Fig. 3 c](#fig3){ref-type="fig"}). This suggests that autophagy alone is not sufficient to drive the acute biophysical changes that we observe after IL-3 depletion.

![**The biophysical response of FL5.12 Bcl-x~L~ cells to autophagy induction.** Volume (a) and density (b) measurements of Torin-treated FL5.12 cells show a slight decrease in volume and a larger decrease in density. Time refers to time elapsed since Torin treatment. \*, P \< 9 × 10^−3^; \*\*, P \< 5 × 10^−32^; N.S., no significance. Western blots of LC3 in FL5.12 cells treated with Torin (c) or withdrawn from IL-3 (d) over time. Note the conversion of the slower-migrating LC3-I to the more rapidly migrating, lipidated LC3 species, LC3-II, indicating induction of autophagy (c and d).](JCB_201506118_Fig3){#fig3}

The earliest time that has been previously reported for increased autophagy after IL-3 withdrawal in FL5.12 Bcl-x~L~ cells is ∼48 h ([@bib24]). However, density and volume begin to shift within at most 12 h of IL-3 depletion ([Fig. 2](#fig2){ref-type="fig"} and [Fig. S2, a and b](http://www.jcb.org/cgi/content/full/jcb.201506118/DC1){#supp3}). To determine if autophagy contributes to the biophysical changes that we observe after IL-3 depletion, we measured the conversion of LC3-I to LC3-II over time in IL-3--depleted FL5.12 Bcl-x~L~ cells. LC3-II expression begins to increase ∼18 h after IL-3 withdrawal, with maximum levels not reached until 36 h of growth factor deprivation ([Fig. 3 d](#fig3){ref-type="fig"}), much later than the appearance of the biophysical response. Furthermore, we used shRNA to decrease expression of autophagy related 7 (ATG7), a protein necessary for autophagy induction (Fig. S2 c). Consistent with previous studies, ATG7 expression is required to maintain viability over longer time periods of IL-3 deprivation, but not at 24 h (Fig. S2 d; [@bib24]). Also, knockdown of ATG7 did not impact the biophysical response of FL5.12 Bcl-x~L~ cells to IL-3 withdrawal at 24 h (Fig. S2, e and f). Thus, these data support our hypothesis that the biophysical changes resulting from IL-3 withdrawal occur before, and independently of, the initiation of autophagy.

Biophysical changes support adaptation to decreased nutrient uptake {#s05}
-------------------------------------------------------------------

We hypothesized that the acute biophysical changes after growth factor withdrawal could represent a metabolic adaptation to decreased nutrient uptake. In the absence of IL-3, FL5.12 Bcl-x~L~ cells stop proliferating ([@bib44]; Table S1) and greatly reduce nutrient uptake ([@bib44]; [@bib47]); however, homeostatic processes such as preserving cell membrane integrity and ion gradients continue to require ATP. Importantly, these processes consume relatively more ATP than do cell biosynthesis and growth ([@bib26]), and meeting these fixed demands for ATP is critical for cell survival. Thus, we considered the possibility that the decrease in cell size and increase in density might partially compensate for decreased ATP production by decreasing the amount of ATP required to perform maintenance processes.

To confirm that the capacity for ATP production is reduced after IL-3 depletion, we measured nutrient and oxygen consumption in FL5.12 Bcl-x~L~ cells in the presence and absence of IL-3. In agreement with previous studies, both glucose and glutamine consumption are significantly suppressed in IL-3--depleted cells ([Fig. 4, a and b](#fig4){ref-type="fig"}; [@bib13]; [@bib33]). One source of ATP is fermentation of glucose to lactate. Consistent with decreased glucose consumption, lactate production is also abolished in IL-3--depleted cells ([Fig. 4 c](#fig4){ref-type="fig"}). The other major source of ATP production in cells is mitochondrial oxidative phosphorylation, which is fueled by oxidation of TCA cycle intermediates and fatty acids. As shown in [Fig. 4 d](#fig4){ref-type="fig"}, oxygen consumption is decreased, but not eliminated, in IL-3 withdrawn FL5.12 Bcl-x~L~ cells, indicating that oxidative phosphorylation is the sole source of ATP production. This oxygen consumption is primarily supported by glutamine oxidation with a contribution from fatty acid oxidation ([Fig. S3, a and b](http://www.jcb.org/cgi/content/full/jcb.201506118/DC1){#supp4}). Regardless, the decreased mitochondrial respiration and the loss of glycolysis indicate that ATP synthesis capacity is decreased in IL-3--withdrawn FL5.12 Bcl-x~L~ cells. Interestingly, we observe that neither the ATP to ADP ratio nor the ATP to AMP ratio is significantly affected at this time point in FL5.12 Bcl-x~L~ cells after IL-3 depletion, suggesting a concomitant reduction in ATP consumption (Fig. S3, c and d). Thus, these cells must rely on additional adaptations to support survival despite decreased ATP production.

![**Changes in FL5.12 Bcl-x~L~ cell metabolism after IL-3 depletion.** IL-3 depletion causes decreases in glucose consumption rate (a), glutamine consumption rate (b), lactate production rate (c), and mitochondrial oxygen consumption rate (d). Glucose depletion leads to a decrease in viability in FL5.12 Bcl-x~L~ cells exposed to IL-3, though not to cells depleted of IL-3 (e). \*, P \< 7.2 × 10^−3^; \*\*, P \< 2 × 10^−4^; \*\*\*, P \< 10^−4^; N.S., no significance.](JCB_201506118_Fig4){#fig4}

We considered how decreased ATP consumption could be linked to decreased cell size. Past studies have shown a similar percent increase in oxygen consumption in FL5.12 Bcl-x~L~ cells treated with gramicidin D in both IL-3--depleted and control cases ([@bib43]). Gramicidin D uncouples the plasma membrane Na^+^/K^+^ potential, resulting in a compensatory increase in cytosolic Na^+^/K^+^-ATPase activity to maintain the cell membrane potential, and thereby increases ATP consumption. The increase in ATP consumption requires an increase in ATP production, and gramicidin D has been classically used to drive increased mitochondrial ATP production in cells. The observation that IL-3--replete and depleted cells have a similar fractional increase in ATP production after gramicidin D treatment, and that IL-3--depleted cells have lower ATP production relative to IL-3--replete cells, suggests that IL-3--depleted cells require less ATP production to maintain the plasma membrane potential. Because the energetic cost of maintaining the plasma membrane potential is proportional to the cell surface area, this argues that a reduction in cell size contributes to energy savings. To test this idea, we determined if decreased ATP consumption in smaller, denser cells could be beneficial for cells in low nutrient conditions. Incubation of IL-3--treated FL5.12 Bcl-x~L~ cells with media lacking glucose causes a robust loss of viability after 48 h ([Fig. 4 e](#fig4){ref-type="fig"}). However, withdrawal of IL-3 for 24 h before, and during, a 48-h incubation in glucose-free media shows a relative protection from glucose withdrawal ([Fig. 4 e](#fig4){ref-type="fig"}). Withdrawal of IL-3 did not protect against glutamine deprivation, consistent with the role of glutamine oxidation maintaining ATP in IL-3--depleted FL5.12 Bcl-x~L~ cells (Fig. S3 e). These data demonstrate that withdrawal of IL-3, and the decreased ATP requirements to maintain viability at a smaller size, can promote improved survival in nutrient-depleted conditions.

IL-2 depletion in primary T cells leads to changes in density and volume {#s06}
------------------------------------------------------------------------

Previous studies have demonstrated a significant degree of overlap between the molecular events occurring after IL-3 depletion in FL5.12 Bcl-x~L~ cells and in the differentiation of activated lymphocytes to memory cells; in particular, both circumstances involve decreases in nutrient uptake, shifts in metabolism from glycolysis to oxidative phosphorylation, and upregulation of autophagy and dependence on antiapoptotic protein expression ([@bib17]; [@bib31]). To determine whether similar biophysical changes accompany growth factor withdrawal in primary lymphocytes, we investigated monoclonal CD8^+^ T cells taken from OT-1 transgenic mice and activated with a SIINFEKL peptide in the presence of IL-2. Within 48 h after activation, naive CD8^+^ cells are all proliferating ([@bib20]) and undergo a significant increase in volume and decrease in density ([Fig. S4, a and b](http://www.jcb.org/cgi/content/full/jcb.201506118/DC1){#supp5}). This response is similar to that observed when IL-3--depleted cells are restimulated with IL-3 (Fig. S1, i and j). After the clearance of an infection, levels of IL-2 fall and cellular nutrient uptake is reduced ([@bib3]; [@bib4]). Thus, we next measured the volume and density of a population of activated CD8^+^ cells after IL-2 withdrawal by removing exogenous IL-2 and adding an anti--IL-2 antibody to prevent stimulation from IL-2 produced by the activated cells ([@bib3]). Depletion of IL-2 leads to a decrease in cell volume and increase in cell density that closely resembles what we observe after IL-3 depletion in FL5.12 Bcl-x~L~ cells ([Fig. 5, a and b](#fig5){ref-type="fig"}). A population of CD8^+^ cells cultured continuously in the presence of IL-2 for 48 h after activation for a similar time interval showed a slight decrease in volume but no noticeable change in density (Figs. S4, a and b).

![**Biophysical response of CD8^+^ OT-1 cells to growth factor depletion.** IL-2 depletion leads to a decrease in volume and increase in density in activated CD8^+^ cells (a and b). Exposure to IL-15 also leads to a decrease in volume and increase in density in activated CD8^+^ cells (c and d). \*, P \< 0.01; \*\*, P \< 8 × 10^−4^; \*\*\*, P \< 5 × 10^−18^.](JCB_201506118_Fig5){#fig5}

To more closely model the process of differentiation toward memory cells, we resuspended activated CD8^+^ cells in media depleted of IL-2 and supplemented with IL-15, a homeostatic cytokine that promotes memory differentiation ([@bib4]). Similarly to the case with FL5.12 Bcl-x~L~ cells, autophagy has also been identified as critical for memory cell differentiation; however, previous studies have shown that autophagy is initiated at a late time point ([@bib32]). CD8^+^ cells depleted of IL-2 and supplemented with IL-15 demonstrate a similar decrease in volume and increase in density to those depleted of IL-2 exclusively ([Fig. 5, c and d](#fig5){ref-type="fig"}). Interestingly, the ultimate volume and density of cells exposed to IL-15 is quite similar to that of naive cells before activation (Fig. S4). This similarity possibly reflects shared metabolic and physiological roles of both cell types and further suggests a connection between biophysical properties and cellular metabolism and physiological role.

Discussion {#s07}
==========

We have demonstrated that growth factor depletion in lymphocytes results in a conserved biophysical response that helps promote cell survival in nutrient-poor conditions. We have found that FL5.12 Bcl-x~L~ cells decrease in volume and increase in density after IL-3 depletion and that this change is also observed in primary activated CD8^+^ cells during memory differentiation. We demonstrate that this change occurs before the initiation of autophagy and propose that these biophysical changes comprise an acute adaptation to a nutrient-deprived state.

Although the molecular implications of growth factor presence or absence have been widely studied, the influence of growth factors on the biophysical state of cells has not. We propose that these changes result from a broader process of maximizing metabolic efficiency and optimizing resource allocation in lymphocytes. The tremendous breadth of the immune repertoire of a typical organism requires that most lymphocytes remain quiescent for a majority of their lifetimes, though in a state that is primed for rapid activation. Here, we propose that a high-density, low-volume state assists in the metabolic adaptation to decreased nutrient uptake. Whereas a lower volume reduces the energy required for cellular maintenance processes, a higher density in this low-volume state allows retention of specific cellular material, such as proteins that are energetically expensive to synthesize and could be accessed by autophagy as metabolic substrates. Retaining these materials also decreases the resources required to regrow to a size needed for proliferation if the cells are reactivated.

Interestingly, we find that the changes in cell density and volume occur before autophagy initiation, a process known to be critical for survival of growth factor--depleted lymphocytes over long periods ([@bib24]; [@bib31]; [@bib49]). Autophagy plays several roles in memory lymphocytes, including clearing damaged organelles and macromolecules as well as providing energy under conditions of limited nutrient uptake caused by the absence of stimulatory growth factor. In certain cases, it has been described as the primary source of metabolic precursors after growth factor depletion; however, its initiation has been identified as occurring at relatively late time points, in agreement with our findings ([@bib24]; [@bib31]; [@bib32]). Because ATP turnover in cells occurs on a much faster timescale, adaptations to decreased nutrient uptake are required to maintain ATP levels during the time interval requisite for autophagy initiation. Moreover, we find the biophysical outcomes of pharmacologic induction of autophagy to be different from those of growth factor depletion, causing a slight decrease in cell size and decrease in density with kinetics that are slower than the acute decrease in size observed immediately after growth factor withdrawal. Thus, we propose that before activation of autophagy to support cellular bioenergetics, the cell acutely reduces ATP requirements by decreasing in volume and increasing in density.

Biophysical parameters, such as density and volume, represent the aggregate outcome of multiple complex molecular events trigged by loss of growth factor signaling. Similarly, changes to density or volume likely affect many downstream pathways. For example, molecular crowding resulting from an increase in density has been identified as disruptive to protein folding equilibria and responsible for longer diffusion times ([@bib14]; [@bib1]). These issues could potentially occur in the nonproliferating, high-density cells that we study here; proliferating cells may be better served with a lower density, which is presumably associated with a larger cytoplasm and more space available for protein synthesis, signaling, and other essential cellular processes. This might explain why both naive cells and IL-3--depleted cells increase volume and decrease density before dividing when stimulated with IL-2 or IL-3, respectively. Our results also argue that the acute change in volume after growth factor withdrawal is not only caused by exit from the cell cycle, as the cell volume decreases to less than half of the mean volume of the cycling population. Whether this biophysical response allows adaptation of cells to energy stress in other contexts remains to be determined; these data nonetheless establish a link between cell biophysical properties and cell survival in a nutrient-deprived state.

Materials and methods {#s08}
=====================

Cell culture {#s09}
------------

FL5.12 cells were grown at 37°C in RPMI 1640 media (Life Technologies) supplemented with 10% (vol/vol) FBS (Sigma-Aldrich), 10 ml of antibiotic antimycotic (Life Technologies), and 0.01 mg/ml IL-3 (R&D Scientific). For IL-3 depletion, a confluent (10^6^/ml) culture was washed three times in RPMI without IL-3 and resuspended in RPMI without IL-3 at a concentration of 4 × 10^5^/ml. Approximately 0.25 ml of culture was removed every day for measurement in the SMR. For glucose depletion, a confluent (10^6^/ml) culture was washed three times in RPMI lacking glucose and supplemented with 10% vol/vol dialyzed FBS (Sigma-Aldrich) and resuspended at a concentration of 4 × 10^5^/ml in RPMI supplemented with 10% vol/vol dFBS with or without glucose and/or 0.01 mg/ml IL-3. For Torin treatment, a culture at a concentration of 4 × 10^5^/ml was supplemented with 250 nM Torin 1 (gift of D. Sabatini, Whitehead Institute, Cambridge, MA). OT-I splenocytes were activated in vitro with 1 µg/ml OVA~257-264~ peptide (SIINFEKL; Sigma-Aldrich) in RPMI 1640 with 10% (vol/vol) FBS and 55 µM 2-mercaptoethanol (Life Technologies). For the IL-2 experiments, blasting, viable, CD8^+^ T cells were FACS sorted after 24 h of activation and seeded at a concentration of 2 × 10^5^ cells/ml in media with either 100 U/ml IL-2 (PeproTech) or 1 µg/ml anti-IL2 (JES6-1A12 clone; eBioscience) for the +IL-2 and −IL-2 conditions, respectively. For the IL-15 experiments, cells were FACS sorted after 48 h of activation and seeded at a concentration of 2 × 10^5^ cells/ml in media with either 100 U/ml IL-2 or 10 ng/ml IL-15 (PeproTech). In both cases, t~0~ refers to the time at which the cells were exposed to varying cytokine conditions.

SMR operation {#s10}
-------------

Cell volume and density were measured using the SMR as previously described ([@bib19]). The SMR is a cantilever-based mass sensor with an embedded microfluidic channel ([@bib6]). The cantilever mass determines its resonance frequency; as a cell flows through the channel embedded in the cantilever, the cantilever mass changes, leading to a change in resonance frequency. This change in cantilever mass corresponds to the buoyant mass of a cell, or the mass in a fluid: *m~B~* = *V~cell~*(*ρ~cell~* − *ρ~fluid~*), where *m~B~* refers to cell buoyant mass, *V~cell~* refers to cell volume, *ρ~cell~* refers to cell density, and *ρ~fluid~* refers to fluid density. Thus, cell density and volume can be determined by measuring the buoyant mass of a single cell twice, in two fluids of two different densities ([Fig. 1 a](#fig1){ref-type="fig"}). In this study, we use cell media as a low-density fluid (fluid 1), and an osmotically balanced solution of 30% Optiprep (Sigma-Aldrich) and 70% cell media as the high-density fluid (fluid 2). The SMR is filled with fluid 1 in the left-hand bypass and fluid 2 in the right-hand bypass. A cell sample of ∼250,000/ml is loaded into the left-hand bypass channel of the SMR ([Fig. 1 a](#fig1){ref-type="fig"}). The pressure is adjusted such that a single cell is directed to pass from the left-hand bypass, through the cantilever, and toward the right-hand bypass channel, where it is immersed in fluid 2. As the cell passes through the cantilever this first time, its buoyant mass in fluid 1 is measured. The pressure is again adjusted to flow the cell from the right-hand bypass channel toward the cantilever entrance. The cell then passes through the SMR a second time, during which its buoyant mass in fluid 2 is measured. Once the cell reenters the left-hand bypass channel, it is flushed toward a waste vial, and a new cell is subsequently loaded into the cantilever. Cell samples are typically measured for a period of 60 min. As a validation of measurement accuracy, the volume of a sample of cells measured on the SMR is compared with the population measured on a commercial Coulter counter (Fig. S1 b). Additionally, each dataset is evaluated to ensure that no drifts in density or volume occur over the time course of a measurement. Experiments are controlled via a custom LabVIEW program, and data are processed using a custom MATLAB script.

Cellular dry mass is determined in a similar fashion, as previously described ([@bib15]; [@bib27]). In brief, cells are measured with the technique described in the previous paragraph, though with PBS and D~2~O-PBS (PBS in 90% D~2~O) as the low- and high-density fluids, respectively. The cell membrane is permeable to D~2~O, and so when a cell is measured in D~2~O, its aqueous content is replaced with D~2~O. This produces a buoyant mass measurement representative of the buoyant mass of the nonaqueous material exclusively. Similarly, when the cell is measured in PBS, we can approximate that the composition of the intracellular aqueous content to be similar to PBS; thus, a buoyant mass measurement in PBS would also represent the buoyant mass of the dry material. Thus, the cell buoyant masses in PBS and PBS-D~2~O can be used to determine a mass, volume, and density of cellular nonaqueous material, or its biomolecular content.

Confocal microscopy and high-throughput cell phenotyping {#s11}
--------------------------------------------------------

Cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) for 10 min at room temperature and permeabilized with 0.1% Triton X-100 (Life Technologies) for 10 min. To block nonspecific binding, cells were incubated with PBS (Life Technologies) supplemented with 10% FBS (ATCC) for 30 min. For immunostaining, cells were incubated with anti-mitochondria antibody (Abcam) for 1 h. Nuclear DNA and actin filaments were marked with Hoechst 33342 (Sigma-Aldrich) and Alexa Fluor phalloidin 488 (Life Technologies), respectively. Imaging of immunostained cells was performed with an A1 confocal laser microscope (Nikon) equipped with a 60× oil-immersion objective (Nikon). Immunofluorescence confocal images collected every 1 µm in the z-direction were projected onto the xy plane ([@bib22]; [Fig. 2 c](#fig2){ref-type="fig"}, top). For high-throughput cell phenotyping, fluorescence images of immunostained cells were collected with a fluorescence microscope (TE300; Nikon) equipped with a DS-QiMc camera (Nikon). Nuclear area, cell area, and mitochondria intensity were assessed with a customized MATLAB code ([@bib9]). More than 5,000 cells were assessed per condition ([Fig. 2 d](#fig2){ref-type="fig"}).

Quantification of biomass components {#s12}
------------------------------------

FL5.12 Bcl-x~L~ or WT cells were cultured in RPMI containing tracer amounts of ^14^C glucose for 3 d, when steady-state labeling into each fraction had been reached. Cells were then washed and transferred to fresh ^14^C glucose media with or without IL-3 for 24 h. Cells were lysed using TRIzol reagent (Life Technologies), and protein, RNA, and DNA fractions were extracted and purified according to the manufacturer's instructions. Soluble material after RNA precipitation in the aqueous phase was designated the polar fraction, whereas material in the organic phase after protein precipitation was designated the organic fraction. Radioactivity in each fraction was then quantified by liquid scintillation counting. To account for differences in material input, ratios of each fraction were determined normalized to the DNA fraction.

Immunoblotting {#s13}
--------------

Protein was extracted from 3 × 10^6^ FL5.12 Bcl-x~L~ cells in RIPA buffer containing protease inhibitors (Roche) and measured by Western blot using standard methods. The primary antibodies used were anti-LC3 antibody (PM036; MBL International), anti-ATG7 antibody (2631S; Cell Signaling), and anti--α-tubulin (ab176560; Abcam).

shRNA expression {#s14}
----------------

Validated pLKO.1 shRNA constructs targeting mouse ATG7 were obtained from Sigma-Aldrich. Control pLKO.1 shRNA targeting GFP was a gift from D. Sabatini (plasmid 30323; Addgene; [@bib37]). Virus was produced in 293T cells and used to infect FL5.12 Bcl-x~L~ cells, which were selected in 2 µg/ml puromycin.

Viability {#s15}
---------

Cell viability was determined by propidium iodide (PI) exclusion using standard methods. For IL-3 withdrawal viability assays, FL5.12 WT or FL5.12 Bcl-x~L~ cells were washed and resuspended in media without IL-3 for the indicated amount of time. For glucose and glutamine deprivation experiments, FL5.12 Bcl-x~L~ cells were suspended in media with or without IL-3 for 24 h before and subsequently during a 48-h incubation in media absent glucose or glutamine and compared with replete media. In all viability experiments, cells were then resupended in 1 µg/ml PI, and PI incorporation was measured by flow cytometry (FACS Canto II; BD) and quantified (FACS Diva Software).

Mitochondrial oxygen consumption {#s16}
--------------------------------

Oxygen consumption rate was measured from 10^7^ IL-3--treated or withdrawn FL5.12 Bcl-x~L~ cells/ml using an Oxytherm instrument (Hansatech). The slope of the linear range of oxygen depletion was used to measure basal oxygen consumption rate. Nonmitochondrial oxygen consumption rate was measured after treatment with 2 µM antimycin and 2 µM rotenone. The difference between basal and nonmitochondrial oxygen consumption was calculated to determine mitochondrial oxygen consumption rate. To determine the contribution of glutamine to oxygen consumption, IL-3--withdrawn FL5.12 Bcl-x~L~ cells were deprived of glutamine for 2 h and oxygen consumption rate was determined during glutamine withdrawal and after reconstitution with 2 mM glutamine. Fatty acid oxidation contribution to oxygen consumption was determined by comparing oxygen consumption rate before and after addition of 300 µM etomoxir (Sigma-Aldrich).

Metabolic measurements {#s17}
----------------------

Metabolic excretion and consumption measurements of glucose, glutamine, and lactate from the media of FL5.12 Bcl-x~L~ cells were determined with an YSI 7100MBS (YSI Life Sciences) according to manufacturer's protocols. FL5.12 cells treated with IL-3 or withdrawn from IL-3 for 24 h were resuspended at 3 × 10^6^/ml in fresh RPMI for 3 h and metabolite levels in the media were quantified. The measurements were then normalized to cell number and subtracted from metabolite levels measured in media without cells to determine consumption and production rates in each condition.

Measurement of adenine nucleotides {#s18}
----------------------------------

FL5.12 Bcl-x~L~ cells were washed three times in RPMI and resuspended in media with or without IL-3 for 24 h. Cells were then washed in blood bank saline and extracted with 250 µl ice-cold 60% methanol. 250 µl chloroform was then added followed by vortexing at 4**°**C for 10 min and centrifugation at 4**°**C for 10 min at 16,000 *g*. 40 µl of the upper, aqueous methanol-water phase was then transferred to a liquid chromatography--mass spectrometry tube for analysis. Liquid chromatography--mass spectrometry measurement of ATP, ADP, and AMP was done as detailed in ([@bib40]). To control for changes in total material input upon IL-3 deprivation, quantifications were determined as a ratio of ATP/ADP or ATP/AMP in each condition. To control for potential ionization efficiency differences between adenine nucleotide species, the relative ratios were compared after being normalized to the ratios of the +IL-3 condition.

Statistical analysis {#s19}
--------------------

Box plots in [Figs. 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [S1](http://www.jcb.org/cgi/content/full/jcb.201506118/DC1){#supp6}, S2, and S4 represent the interquartile range of the experimental data, and whiskers represent the 5th and 95th percentile of the data. Statistical significance was determined using a Wilcoxon rank-sum analysis. Error bars in [Figs. 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"} represent standard deviation. Statistical significance in [Figs. 4](#fig4){ref-type="fig"} and S3 was determined using an unpaired, parametric *t* test with Welch's correction.

Online supplemental material {#s20}
----------------------------

Fig. S1 provides additional detail regarding changes to density and volume in FL5.12 Bcl-x~L~ cells, as well as demonstrations of biophysical changes in wild-type FL5.12 cells and FL5.12 Bcl-2 cells. Fig. S2 shows additional experiments investigating the dependence of the observed biophysical phenotype to autophagy. Fig. S3 shows further characterization of changes to the metabolic phenotype of FL5.12 cells after IL-3 depletion. Fig. S4 shows changes to volume and density of OT-1 CD8^+^ cells continually exposed to IL-2. Table S1 shows the doubling time of a culture of FL5.12 cells depleted of IL-3 for 120 h and then reexposed to IL-3 for 96 h. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201506118/DC1>.
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